Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Non-Current Debt (2024 - 2025)

Celularity (CELU) has disclosed Non-Current Debt for 2 consecutive years, with $36.5 million as the latest value for Q2 2025.

  • On a quarterly basis, Non-Current Debt changed N/A to $36.5 million in Q2 2025 year-over-year; TTM through Jun 2025 was $36.5 million, a N/A change, with the full-year FY2024 number at $35.9 million, changed N/A from a year prior.
  • Non-Current Debt was $36.5 million for Q2 2025 at Celularity, roughly flat from $36.5 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $36.5 million in Q1 2025 to a low of $35.9 million in Q4 2024.